De Santis R - Search Results

1

Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy.

Gritt G, Gianatt A, Petronzeii F, De Santis R, Pavoni C, Rossi RL, Cattaneo L, Spagnoli LG, Ferrar S, Ross A, Barbu AM, Rambald A. Gritt G, et al. Among authors: de santis r. Oncotarget. 2018 Mar 30;9(24):17256. doi: 10.18632/oncotarget.25064. eCollection 2018 Mar 30. Oncotarget. 2018. PMID: 29683132 Free PMC article.

2

Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy.

Gritti G, Gianatti A, Petronzelli F, De Santis R, Pavoni C, Rossi RL, Cattaneo L, Spagnoli LG, Ferrari S, Rossi A, Barbui AM, Rambaldi A. Gritti G, et al. Among authors: de santis r. Oncotarget. 2018 Jan 3;9(11):9766-9775. doi: 10.18632/oncotarget.23919. eCollection 2018 Feb 9. Oncotarget. 2018. PMID: 29515769 Free PMC article.

3

Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer.

Vesci L, Milazzo FM, Anastasi AM, Petronzelli F, Chiapparino C, Carollo V, Roscilli G, Marra E, Luberto L, Aurisicchio L, Pacello ML, Spagnoli LG, De Santis R. Vesci L, et al. Among authors: de santis r. Oncotarget. 2016 Jan 5;7(1):914-28. doi: 10.18632/oncotarget.6089. Oncotarget. 2016. PMID: 26575422 Free PMC article.

4

[Corrigendum] Trastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance.

Vesci L, Carollo V, Roscilli G, Aurisicchio L, Ferrara FF, Spagnoli L, De Santis R. Vesci L, et al. Among authors: de santis r. Oncol Rep. 2016 Jan;35(1):602. doi: 10.3892/or.2015.4351. Epub 2015 Oct 26. Oncol Rep. 2016. PMID: 26499228 Free PMC article.

5

Radionuclide Therapy of Unresectable Tumors with AvidinOX and (90)Y-biotinDOTA: Tongue Cancer Paradigm.

Albertoni C, Leoni B, Rosi A, D'Alessio V, Carollo V, Spagnoli LG, van Echteld C, De Santis R. Albertoni C, et al. Among authors: de santis r. Cancer Biother Radiopharm. 2015 Sep;30(7):291-8. doi: 10.1089/cbr.2015.1837. Epub 2015 Jul 13. Cancer Biother Radiopharm. 2015. PMID: 26167947 Free PMC article.

6

Trastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance.

Vesci L, Carollo V, Roscilli G, Aurisicchio L, Ferrara FF, Spagnoli L, De Santis R. Vesci L, et al. Among authors: de santis r. Oncol Rep. 2015 Sep;34(3):1146-52. doi: 10.3892/or.2015.4074. Epub 2015 Jun 24. Oncol Rep. 2015. PMID: 26133490 Free PMC article.

7

AvidinOX-anchored biotinylated trastuzumab and pertuzumab induce down-modulation of ErbB2 and tumor cell death at concentrations order of magnitude lower than not-anchored antibodies.

Milazzo FM, Anastasi AM, Chiapparino C, Rosi A, Leoni B, Vesci L, Petronzelli F, De Santis R. Milazzo FM, et al. Among authors: de santis r. Oncotarget. 2017 Apr 4;8(14):22590-22605. doi: 10.18632/oncotarget.15145. Oncotarget. 2017. PMID: 28186982 Free PMC article.

8

Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab.

De Santis R, Rosi A, Anastasi AM, Chiapparino C, Albertoni C, Leoni B, Pelliccia A, Santapaola D, Carollo V, Marra E, Aurisicchio L, Arseni B, Pacello ML, Palmieri G, Battella S, Petronzelli F, Milazzo FM. De Santis R, et al. Oncotarget. 2014 Oct 15;5(19):9239-55. doi: 10.18632/oncotarget.2409. Oncotarget. 2014. PMID: 25238453 Free PMC article.

9

Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitor.

Vesci L, Bernasconi E, Milazzo FM, De Santis R, Gaudio E, Kwee I, Rinaldi A, Pace S, Carollo V, Giannini G, Bertoni F. Vesci L, et al. Among authors: de santis r. Oncotarget. 2015 Mar 20;6(8):5735-48. doi: 10.18632/oncotarget.3240. Oncotarget. 2015. PMID: 25671299 Free PMC article.

10

Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery.

Milazzo FM, Chaves-Sanjuan A, Minenkova O, Santapaola D, Anastasi AM, Battistuzzi G, Chiapparino C, Rosi A, Merlo Pich E, Albertoni C, Marra E, Luberto L, Viollet C, Spagnoli LG, Riccio A, Rossi A, Santoro MG, Ballabio F, Paissoni C, Camilloni C, Bolognesi M, De Santis R. Milazzo FM, et al. Among authors: de santis r. Mol Ther. 2023 Feb 1;31(2):362-373. doi: 10.1016/j.ymthe.2022.09.010. Epub 2022 Sep 15. Mol Ther. 2023. PMID: 36114671 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

384 results

Search Page